-
03 Octobre 2024
-
03 Octobre 2024
An update for healthcare professionals and patients on Increlex® (mecasermin) Injection
This important medicine, and all associated activities, will be transferred to Eton Pharmaceuticals following the signing of an asset transfer agreement. This agreement is expected to complete at the end of 2024. ...
-
08 Avril 2024
-
08 Avril 2024
Patient organizations and industry stakeholders
Who is the controller of your personal information?...